Conference Coverage

VIDEO: Stress alleviation strategies boost inflammatory skin treatment regimens


 

AT AAD 17

– “Consider the effects of the mind on the skin when treating patients with some skin diseases.” That was the message of several speakers during a session titled “The Skin and the Mind” at the annual meeting of the American Academy of Dermatology.

“I certainly believe that the time has come to use stress alleviation techniques, at least for selected patients, and this should certainly be part of our armamentarium in the clinic,” said Richard D. Granstein, MD, George W. Hambrick Jr. professor and chairman of the department of dermatology, Cornell University, New York. During the session, he spoke about the emerging science of stress in dermatology.

While it has long been believed that stress exacerbates different skin diseases, the connection has been difficult to prove scientifically, he pointed out. However, “the overwhelming number of reports and studies indicate that stress probably does exacerbate a number of inflammatory skin diseases,” he added.

In a video interview at the meeting, Dr. Granstein notes that a number of pathways that help explain this link have now been identified and discusses one of those pathways, which involves neuropeptides and future directions in understanding the relationship between stress and inflammatory skin diseases.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Dr. Granstein disclosed serving as an advisor to Castle Biosciences, Elysium Health, Galderma Laboratories, and Velius.

Recommended Reading

Biosimilars in Psoriasis: The Future or Not?
MDedge Dermatology
Resolution of Psoriatic Lesions on the Gingiva and Hard Palate Following Administration of Adalimumab for Cutaneous Psoriasis
MDedge Dermatology
Psoriatic Arthritis Treatment: The Dermatologist’s Role
MDedge Dermatology
Perioperative infliximab does not increase serious infection risk
MDedge Dermatology
Subcutaneous high-dose methotrexate controls psoriasis
MDedge Dermatology
Brodalumab approved for psoriasis with REMS required
MDedge Dermatology
Humira Pen topped per-person drug spending in 2016
MDedge Dermatology
Psoriasis and depression may pack a PsA punch
MDedge Dermatology
CIMPASI-1 and -2 show certolizumab pegol benefits patients with severe plaque psoriasis
MDedge Dermatology
Infection Risk With Biologic Therapy for Psoriasis: Report From the AAD Meeting
MDedge Dermatology